Literature DB >> 12350108

Isolation and characterization of modified species of a mutated (Cys125 -Ala) recombinant human interleukin-2.

Galina Moya1, Luis Javier González, Vivian Huerta, Yairet García, Vivian Morera, Danny Pérez, Fidel Breña, Manuel Araña.   

Abstract

During purification of recombinant and mutated interleukin-2 (rhIL-2A125) by reversed-phase-high-performance liquid chromatography, more and less hydrophobic fractions named MHF and LHF, respectively are discarded due to the presence of some unidentified forms of rhIL-2Ala125. Using slow and linear gradients of acetonitrile, these fractions were further purified by RP-HPLC, analyzed by automatic Edman degradation, digested with trypsin and analyzed by electrospray ionization mass spectrometry. In all fractions, partial processing of the N-terminal Met residue was observed. In the LHF the Met104 was partially oxidized as sulfoxide. Combining the selective and reversible blocking of tryptic peptides and cation-exchange chromatography, two unexpected C-terminal peptides were selectively isolated. Automatic N-terminal sequencing showed that one of these corresponded to the C-terminal peptide of rhIL-2Ala125 linked to another 11 amino acids (AANDENYALAA) and the other corresponded to the C-terminal peptide of a truncated rhIL-2Ala125 without the C-terminal threonine residue and the extension of the 11 amino acids previously mentioned. MHF contained a mixture of four species of rhIL-2A125 monoacetylated at the N-terminus and at the epsilon-amino groups of internal Lys residues: 8, 32 and 48. Cys58 was found as free cysteine and also covalently linked to Mr 69 and 77 molecules. Covalent dimers of rhIL-2A125 linked through disulfide bridges between Cys58 and Cys105 of different monomers were also found.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12350108     DOI: 10.1016/s0021-9673(02)00845-2

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

1.  Construction of the plasmid coding for the expression of the EGFP-M-IL-2(88Arg, 125Ala) fusion protein and the anti-tumor effects exerted by the fusion protein in HeLa-60 cells.

Authors:  Guangcan Shao; Dongmeng Qian; Haitao Wang; Zhiyong Yan; Ming Hu; Tongmei Wang; Bin Wang
Journal:  Oncol Lett       Date:  2015-04-20       Impact factor: 2.967

Review 2.  Bacterial protein acetylation: new discoveries unanswered questions.

Authors:  Alan J Wolfe
Journal:  Curr Genet       Date:  2015-12-12       Impact factor: 3.886

3.  Isolation and Characterization of Acetylated Derivative of Recombinant Insulin Lispro Produced in Escherichia coli.

Authors:  Joanna Szewczak; Anna Bierczyńska-Krzysik; Marcin Piejko; Paweł Mak; Dorota Stadnik
Journal:  Pharm Res       Date:  2015-02-07       Impact factor: 4.200

4.  In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum.

Authors:  Luis Ariel Espinosa; Yassel Ramos; Ivan Andújar; Enso Onill Torres; Gleysin Cabrera; Alejandro Martín; Diamilé Roche; Glay Chinea; Mónica Becquet; Isabel González; Camila Canaán-Haden; Elías Nelson; Gertrudis Rojas; Beatriz Pérez-Massón; Dayana Pérez-Martínez; Tamy Boggiano; Julio Palacio; Sum Lai Lozada Chang; Lourdes Hernández; Kathya Rashida de la Luz Hernández; Saloheimo Markku; Marika Vitikainen; Yury Valdés-Balbín; Darielys Santana-Medero; Daniel G Rivera; Vicente Vérez-Bencomo; Mark Emalfarb; Ronen Tchelet; Gerardo Guillén; Miladys Limonta; Eulogio Pimentel; Marta Ayala; Vladimir Besada; Luis Javier González
Journal:  Anal Bioanal Chem       Date:  2021-11-05       Impact factor: 4.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.